Hinge Health (NYSE:HNGE) CEO Daniel Antonio Perez Sells 104,544 Shares

Hinge Health Inc. (NYSE:HNGE) CEO Daniel Antonio Perez sold 104,544 shares of the stock in a transaction that occurred on Wednesday, May 6th. The shares were sold at an average price of $55.09, for a total transaction of $5,759,328.96. Following the transaction, the chief executive officer owned 35,470 shares in the company, valued at $1,954,042.30. The trade was a 74.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Daniel Antonio Perez also recently made the following trade(s):

• On Thursday, May 7th, Daniel Antonio Perez sold 45,456 shares of Hinge Health stock. The shares were sold at an average price of $55.05, for a total transaction of $2,502,352.80.
• On Thursday, February 12th, Daniel Antonio Perez sold 166,665 shares of Hinge Health stock. The shares were sold at an average price of $40.26, for a total transaction of $6,709,932.90.

Hinge Health Price Performance

Shares of NYSE HNGE opened at $55.89 on Friday. Hinge Health Inc. has a one year low of $30.08 and a one year high of $62.18. The firm’s 50 day simple moving average is $42.81 and its two-hundred day simple moving average is $44.00. The stock has a market capitalization of $4.40 billion and a P/E ratio of -4.53.

Hinge Health (NYSE:HNGE) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.12 by $0.33. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 279.39%. The business had revenue of $182.31 million for the quarter. During the same quarter in the previous year, the business earned $1.30 earnings per share. The firm’s revenue was up 47.2% on a year-over-year basis. As a group, equities analysts expect that Hinge Health Inc. will post 0.78 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently weighed in on HNGE shares. Evercore reissued an “outperform” rating and set a $45.00 price objective on shares of Hinge Health in a research note on Wednesday, April 8th. Weiss Ratings raised Hinge Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday. Citigroup reissued an “outperform” rating on shares of Hinge Health in a research note on Wednesday. Raymond James Financial reissued an “outperform” rating and set a $70.00 price objective on shares of Hinge Health in a research note on Wednesday. Finally, Stifel Nicolaus increased their price objective on Hinge Health from $59.00 to $67.00 and gave the company a “buy” rating in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Hinge Health has a consensus rating of “Moderate Buy” and an average price target of $67.40.

Hedge Funds Weigh In On Hinge Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. lifted its position in Hinge Health by 172.7% during the first quarter. PNC Financial Services Group Inc. now owns 9,898 shares of the company’s stock valued at $382,000 after buying an additional 6,268 shares during the period. Swiss National Bank lifted its position in Hinge Health by 8.1% during the first quarter. Swiss National Bank now owns 34,800 shares of the company’s stock valued at $1,342,000 after buying an additional 2,600 shares during the period. Bank of New York Mellon Corp purchased a new position in Hinge Health during the first quarter valued at $292,000. Emerald Mutual Fund Advisers Trust purchased a new position in Hinge Health during the first quarter valued at $7,009,000. Finally, Emerald Advisers LLC purchased a new position in Hinge Health during the first quarter valued at $10,754,000.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.